Jane Street’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.12M Sell
143,838
-139,366
-49% -$3.02M ﹤0.01% 1728
2025
Q1
$6.87M Buy
283,204
+245,953
+660% +$5.96M ﹤0.01% 1097
2024
Q4
$777K Sell
37,251
-364,657
-91% -$7.61M ﹤0.01% 3293
2024
Q3
$7.99M Buy
401,908
+285,564
+245% +$5.68M ﹤0.01% 900
2024
Q2
$1.8M Buy
116,344
+52,989
+84% +$821K ﹤0.01% 2873
2024
Q1
$1.01M Sell
63,355
-29,127
-31% -$464K ﹤0.01% 3193
2023
Q4
$1.55M Sell
92,482
-84,835
-48% -$1.43M ﹤0.01% 2795
2023
Q3
$2.07M Buy
177,317
+85,911
+94% +$1M ﹤0.01% 2208
2023
Q2
$1.23M Sell
91,406
-11,062
-11% -$149K ﹤0.01% 2860
2023
Q1
$1.7M Buy
102,468
+59,171
+137% +$981K ﹤0.01% 2236
2022
Q4
$805K Buy
43,297
+30,127
+229% +$560K ﹤0.01% 2876
2022
Q3
$169K Sell
13,170
-10,975
-45% -$141K ﹤0.01% 4674
2022
Q2
$169K Sell
24,145
-51,125
-68% -$358K ﹤0.01% 4534
2022
Q1
$624K Buy
75,270
+57,637
+327% +$478K ﹤0.01% 3494
2021
Q4
$119K Sell
17,633
-7,691
-30% -$51.9K ﹤0.01% 4605
2021
Q3
$134K Buy
25,324
+4,312
+21% +$22.8K ﹤0.01% 4587
2021
Q2
$121K Buy
+21,012
New +$121K ﹤0.01% 4682
2021
Q1
Sell
-32,654
Closed -$109K 4998
2020
Q4
$109K Sell
32,654
-132,048
-80% -$441K ﹤0.01% 3626
2020
Q3
$489K Buy
164,702
+150,741
+1,080% +$448K ﹤0.01% 2452
2020
Q2
$65K Buy
+13,961
New +$65K ﹤0.01% 3739
2019
Q4
Sell
-24,776
Closed -$132K 3335
2019
Q3
$132K Buy
+24,776
New +$132K ﹤0.01% 3139
2018
Q1
Sell
-18,720
Closed -$73K 3142
2017
Q4
$73K Sell
18,720
-5,279
-22% -$20.6K ﹤0.01% 2911
2017
Q3
$60K Buy
+23,999
New +$60K ﹤0.01% 2777
2016
Q3
Sell
-65,594
Closed -$47K 2748
2016
Q2
$47K Buy
+65,594
New +$47K ﹤0.01% 2516
2014
Q4
Sell
-46,039
Closed -$153K 1879
2014
Q3
$153K Buy
+46,039
New +$153K ﹤0.01% 1950
2014
Q1
Sell
-42,460
Closed -$83K 2422
2013
Q4
$83K Sell
42,460
-5,688
-12% -$11.1K ﹤0.01% 1940
2013
Q3
$147K Buy
+48,148
New +$147K ﹤0.01% 2195